Aytu BioScience Inc Cash Flow-to-Debt Ratio
Aytu BioScience Inc cash flow-to-debt ratio. Aytu BioScience Inc (AYTU) has a Cash Flow-to-Debt Ratio of -0.05x as of March 2026, meaning its operating cash flow of $-4.18 Million could theoretically repay 0% of its total liabilities ($76.55 Million) in one year. Check cash flow quality index of Aytu BioScience Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aytu BioScience Inc (2007–2025)
Cash flow-to-debt ratio of Aytu BioScience Inc from 2007 to 2025. Historical debt coverage capacity for Aytu BioScience Inc across 19 annual periods. Check Aytu BioScience Inc (AYTU) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Aytu BioScience Inc Cash Flow-to-Debt Ratio by Year (2007–2025)
Aytu BioScience Inc cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Aytu BioScience Inc. For the full cash flow conversion analysis, see AYTU cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.02x | $-1.94 Million | $105.21 Million | ▼ -20.9% |
| 2024 | -0.02x | $-1.39 Million | $91.14 Million | ▲ +70.8% |
| 2023 | -0.05x | $-5.13 Million | $98.48 Million | ▲ +83.1% |
| 2022 | -0.31x | $-28.82 Million | $93.31 Million | ▼ -52.4% |
| 2021 | -0.20x | $-25.96 Million | $128.10 Million | ▲ +58.7% |
| 2020 | -0.49x | $-28.37 Million | $57.82 Million | ▲ +2.0% |
| 2019 | -0.50x | $-13.83 Million | $27.63 Million | ▲ +76.0% |
| 2018 | -2.09x | $-15.94 Million | $7.64 Million | ▼ -66.0% |
| 2017 | -1.26x | $-13.83 Million | $11.00 Million | ▼ -68.2% |
| 2016 | -0.75x | $-10.66 Million | $14.26 Million | ▲ +70.6% |
| 2015 | -2.54x | $-6.63 Million | $2.61 Million | ▼ -207.0% |
| 2014 | -0.83x | $-5.50 Million | $6.65 Million | ▼ -164.6% |
| 2013 | -0.31x | $-37.70K | $120.53K | ▲ +31.9% |
| 2012 | -0.46x | $-37.85K | $82.36K | ▲ +58.6% |
| 2011 | -1.11x | $-64.82K | $58.43K | ▼ -111.5% |
| 2010 | -0.52x | $-43.38K | $82.70K | ▲ +37.6% |
| 2009 | -0.84x | $-46.63K | $55.44K | ▲ +9.7% |
| 2008 | -0.93x | $-44.80K | $48.12K | ▼ -36.3% |
| 2007 | -0.68x | $-27.92K | $40.87K | — |